Interaksi Akamprosat

Akamprosat (Campral) memiliki 12 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 0 mayor, 0 moderat, 1 minor, dan 11 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Seperti apa tampilan Akamprosat

Semua 6 versi
Tablet Akamprosat 333 mg: putih, bulat, 10 mm, dengan kode cetak 333.
333
333 mg · putih · bulat · 10 mm
Carilion Materials Managem…
Tablet Akamprosat 333 mg: putih, bulat, 10 mm, dengan kode cetak 569.
569
333 mg · putih · bulat · 10 mm
Zydus Pharmaceuticals (USA)
Tablet Akamprosat 333 mg: putih, bulat, 10 mm, dengan kode cetak 435.
435
333 mg · putih · bulat · 10 mm
Glenmark Pharmaceuticals
Tablet Akamprosat 333 mg: putih, bulat, 10 mm, dengan kode cetak AC476.
AC476
333 mg · putih · bulat · 10 mm
Somerset Therapeutics

Gambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 6 versi terdokumentasi dari 7 pelabel.

Interaksi dari label

Penyebutan minor (1)

  • AlkoholAlkoholMinor

    Alcohol Withdrawal Use of acamprosate calcium does not eliminate or diminish withdrawal symptoms. (label Akamprosat, Peringatan dan perhatian)

Tidak ada interaksi bermakna yang dilaporkan (11)

  • Alvimopanantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • DiazepambenzodiazepinTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Disulfirampenghambat CYP2C9Tanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Metilnaltreksonantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Naldemedinantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Nalmefenantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Naloksegolantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Naloksonantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Naltreksonantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Naltrekson dan bupropionantagonis opioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

  • Pentazosin dan naloksonopioidTanpa interaksi

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (label Akamprosat, Interaksi obat)

Periksa Akamprosat terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.